Evidence map›Paper›PMID 41376653›Full record

ArticleJournal of the Endocrine Society2026

Effect of Continuous Glucose Monitoring Following Hospital Discharge of Patients With Type 2 Diabetes.

Cecilia Wallace, Melanie Natasha Rayan, Sara Folk, Cara Harris, Eileen Faulds, Thaina Gatti, Philicia Duncan, Elizabeth Buschur, Kathleen Wyne, Trevor Sobol and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of the Endocrine Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Cecilia WallaceThe Ohio State University College of Medicine, Columbus, OH 43210, USA.
Melanie Natasha RayanDivision of Endocrinology, Diabetes and Metabolism, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.ORCID https://orcid.org/0009-0005-0646-5508
Sara FolkThe Ohio State University College of Medicine, Columbus, OH 43210, USA.
Cara HarrisDivision of Endocrinology, Diabetes and Metabolism, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.
Eileen FauldsDivision of Endocrinology, Diabetes and Metabolism, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.ORCID https://orcid.org/0000-0003-2315-1146
Thaina GattiDivision of Endocrinology, Diabetes and Metabolism, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.
Philicia DuncanDivision of Hospital Medicine, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.
Elizabeth BuschurDivision of Endocrinology, Diabetes and Metabolism, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.
Kathleen WyneDivision of Endocrinology, Diabetes and Metabolism, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.
Trevor SobolThe Ohio State University College of Medicine, Columbus, OH 43210, USA.
Jianing MaCenter for Biostatistics, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.
Kathleen M DunganDivision of Endocrinology, Diabetes and Metabolism, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.ORCID https://orcid.org/0000-0003-1289-1595

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Context: The post-hospitalization period is a vulnerable time for patients with type 2 diabetes (T2D). Objective: To assess usefulness of continuous glucose monitoring (CGM) for optimizing glucose levels and supporting medication use and behavioral change. Methods: We conducted a prospective, nonrandomized study of hospitalized adults with type 2 diabetes, HbA1c > 8%, and requiring ≥10 units of basal insulin daily. Participants received the Dexcom G6 and had follow-up visits at week 2, 4, 8, and 12 following discharge. The primary focus of analysis was change in HbA1c from 0 to 12 weeks. Secondary outcomes included CGM metrics, remote monitoring capability, and healthcare utilization. Results: Among 108 enrolled participants, 51% were monitored remotely, 79% had CGM data post-discharge, and 61% completed the 12-week visit. HbA1c (%) declined from 12% (interquartile range [IQR] 10%, 14%) to 8.2% (IQR 6.9%, 9.3%) ( Conclusion: Initiating CGM at hospital discharge was feasible, safe, and associated with significant glycemic improvement at 12 weeks. Additional studies are needed to optimize the implementation of CGM following discharge.

Indexed as

continuous glucose monitorhospitaltype 2 diabetes

Identifiers

PMID41376653
PMCPMC12686665

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.